Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies

S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng… - Pharmacological …, 2021 - ASPET
The endothelium, a cellular monolayer lining the blood vessel wall, plays a critical role in
maintaining multiorgan health and homeostasis. Endothelial functions in health include …

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …

Immune responses during COVID-19 infection

C Melenotte, A Silvin, AG Goubet, I Lahmar… - …, 2020 - Taylor & Francis
Over the past 16 years, three coronaviruses (CoVs), severe acute respiratory syndrome CoV
(SARS-CoV) in 2002, Middle East respiratory syndrome CoV (MERS-CoV) in 2012 and …

Major coagulation disorders and parameters in COVID-19 patients

A Teimury, MT Khameneh, EM Khaledi - European journal of medical …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), with a high prevalence rate, has rapidly
infected millions of people around the world. Since viral infections can disrupt the …

Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes

A De Vito, V Fiore, E Princic, N Geremia… - PLoS …, 2021 - journals.plos.org
Introduction Since the start of the pandemic, millions of people have been infected, with
thousands of deaths. Many foci worldwide have been identified in retirement nursing homes …

[HTML][HTML] Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases

H Tanzadehpanah, E Lotfian, A Avan, S Saki… - Biomedicine & …, 2023 - Elsevier
The occurrence of a novel coronavirus known as severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), created a serious challenge worldwide. SARS-CoV-2 has …

Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia

S Araya, MA Mamo, YG Tsegay, A Atlaw, A Aytenew… - Plos one, 2021 - journals.plos.org
Background Coagulopathy and thromboembolic events are among the complications of
Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 …

SARS-CoV-2 and atherosclerosis: should COVID-19 be recognized as a new predisposing cardiovascular risk factor?

M Vinciguerra, S Romiti, GM Sangiorgi, D Rose… - Journal of …, 2021 - mdpi.com
At the beginning of the COVID-19 pandemic, the lung was recognized as the main target
organ; now, new evidence suggests that SARS-CoV-2 infection leads to vascular disease. In …

A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms

X Tang, F Zheng - Neurological sciences, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), the third type of coronavirus pneumonia
after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome …

Therapeutic potential of annexins in sepsis and COVID-19

L Mui, CM Martin, BJ Tschirhart, Q Feng - Frontiers in Pharmacology, 2021 - frontiersin.org
Sepsis is a continuing problem in modern healthcare, with a relatively high prevalence, and
a significant mortality rate worldwide. Currently, no specific anti-sepsis treatment exists …